Systemic sclerosis : nature.com subject feedshttps://www.nature.com/subjects/systemic-sclerosis.atom2024-03-28T12:55:28+00:00Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosishttps://www.nature.com/articles/s41598-024-56221-z2024-03-06T00:00:00+00:002024-03-06T00:00:00+00:00Ayaka Sugimori et al.GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor regionhttps://www.nature.com/articles/s41467-023-44541-z2024-01-31T00:00:00+00:002024-01-31T00:00:00+00:00Yuki Ishikawa et al.S100A4 inhibition targets fibrosis in SSchttps://www.nature.com/articles/s41584-024-01080-12024-01-11T00:00:00+00:002024-01-11T00:00:00+00:00Jessica McHughReproducibility of pulmonary function tests in patients with systemic sclerosishttps://www.nature.com/articles/s41598-023-45881-y2023-11-03T00:00:00+00:002023-11-03T00:00:00+00:00P. Jacquerie et al.Systemic sclerosis interstitial lung disease: unmet needs and potential solutionshttps://www.nature.com/articles/s41584-023-01044-x2023-11-03T00:00:00+00:002023-11-03T00:00:00+00:00Vasiliki Liakouli et al.Back to the future: targeting the extracellular matrix to treat systemic sclerosishttps://www.nature.com/articles/s41584-023-01032-12023-10-03T00:00:00+00:002023-10-03T00:00:00+00:00Andrew Leask et al.Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosishttps://www.nature.com/articles/s41598-023-42464-92023-09-12T00:00:00+00:002023-09-12T00:00:00+00:00Silvia Speca et al.Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?https://www.nature.com/articles/s41584-023-01013-42023-08-21T00:00:00+00:002023-08-21T00:00:00+00:00Kristofer Andréasson et al.Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?https://www.nature.com/articles/s41584-023-01014-32023-08-21T00:00:00+00:002023-08-21T00:00:00+00:00Janet E. PopePrognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective studyhttps://www.nature.com/articles/s41598-023-37141-w2023-06-22T00:00:00+00:002023-06-22T00:00:00+00:00Yoichi Nakayama et al.Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung diseasehttps://www.nature.com/articles/s41598-023-35840-y2023-05-27T00:00:00+00:002023-05-27T00:00:00+00:00Giuliana Cerro-Chiang et al.State-of-the-art evidence in the treatment of systemic sclerosishttps://www.nature.com/articles/s41584-023-00909-52023-02-27T00:00:00+00:002023-02-27T00:00:00+00:00Janet E. Pope et al.Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and managementhttps://www.nature.com/articles/s41584-022-00900-62023-02-06T00:00:00+00:002023-02-06T00:00:00+00:00Zsuzsanna H. McMahan et al.Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organshttps://www.nature.com/articles/s41467-023-36285-72023-01-31T00:00:00+00:002023-01-31T00:00:00+00:00Wenxia Wang et al.Fibroblast A20 and its suppressor DREAM regulate fibrosis in SSchttps://www.nature.com/articles/s41584-022-00886-12022-12-07T00:00:00+00:002022-12-07T00:00:00+00:00Sarah OnuoraFibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organshttps://www.nature.com/articles/s41467-022-33767-y2022-10-26T00:00:00+00:002022-10-26T00:00:00+00:00Wenxia Wang et al.Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosishttps://www.nature.com/articles/s41525-022-00327-82022-10-05T00:00:00+00:002022-10-05T00:00:00+00:00Martin Kerick et al.Thy-1 promotes skin fibrosis in SSchttps://www.nature.com/articles/s41584-022-00858-52022-10-04T00:00:00+00:002022-10-04T00:00:00+00:00Robert PhillipsAssessment of disease outcome measures in systemic sclerosishttps://www.nature.com/articles/s41584-022-00803-62022-07-20T00:00:00+00:002022-07-20T00:00:00+00:00Robert Lafyatis et al.A pilot study of nailfold capillaroscopy in hereditary transthyretin amyloidosishttps://www.nature.com/articles/s41598-022-15779-22022-07-09T00:00:00+00:002022-07-09T00:00:00+00:00Dayoung Kim et al.To choose or not? The value of discrete-choice experiments in rheumatologyhttps://www.nature.com/articles/s41584-022-00799-z2022-06-09T00:00:00+00:002022-06-09T00:00:00+00:00Janet E. PopeImpact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertensionhttps://www.nature.com/articles/s41598-022-09353-z2022-03-28T00:00:00+00:002022-03-28T00:00:00+00:00Alfredo Guillén-Del-Castillo et al.Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical needhttps://www.nature.com/articles/s41584-022-00765-92022-03-15T00:00:00+00:002022-03-15T00:00:00+00:00Ariane L. Herrick et al.Tofacitinib and metformin reduce the dermal thickness and fibrosis in mouse model of systemic sclerosishttps://www.nature.com/articles/s41598-022-06581-12022-02-15T00:00:00+00:002022-02-15T00:00:00+00:00Ahmet Karatas et al.High prevalence of occult left ventricular diastolic dysfunction detected by exercise stress test in systemic sclerosishttps://www.nature.com/articles/s41598-022-06400-72022-02-14T00:00:00+00:002022-02-14T00:00:00+00:00Takato Mohri et al.Evaluating early diagnostic criteria for SSchttps://www.nature.com/articles/s41584-021-00745-52022-01-07T00:00:00+00:002022-01-07T00:00:00+00:00Robert PhillipsGlobal gene expression analysis of systemic sclerosis myofibroblasts demonstrates a marked increase in the expression of multiple NBPF geneshttps://www.nature.com/articles/s41598-021-99292-y2021-10-14T00:00:00+00:002021-10-14T00:00:00+00:00Giuseppina Abignano et al.Capsule endoscopy findings reflect the gastrointestinal conditions of patients with systemic sclerosishttps://www.nature.com/articles/s41598-021-99775-y2021-10-11T00:00:00+00:002021-10-11T00:00:00+00:00Sumio Iio et al.Detection of microvascular changes in systemic sclerosis and other rheumatic diseaseshttps://www.nature.com/articles/s41584-021-00685-02021-09-24T00:00:00+00:002021-09-24T00:00:00+00:00Maurizio Cutolo et al.Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potentialhttps://www.nature.com/articles/s41584-021-00683-22021-09-03T00:00:00+00:002021-09-03T00:00:00+00:00Pei-Suen Tsou et al.